A Study on Rheumatoid Arthritis Patients Treated With Rituximab
NCT02622503 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81
Last updated 2016-12-13
Summary
The purpose of the study is to obtain an overall picture of rituximab treatments and treatment responses in RA patients.
Conditions
Interventions
- DRUG
-
This is an observational study. Patients with rheumatoid arthritis and having received treatment previously will be assessed for the treatment responses.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Trials · Hoffmann-La Roche
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-04-30
- Primary Completion
- 2008-08-31
- Completion
- 2008-08-31
Countries
- Finland
Study Locations
More Related Trials
-
Observational Safety Study of Rituximab in Patients Diagnosed With Rheumatoid Arthritis (RA) Who Did Not Respond Adequately to TNF-alpha Blocker
NCT02322801 ·Status: COMPLETED
-
A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
NCT00422383 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)
NCT01565122 ·Status: COMPLETED
-
An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With Rituximab
NCT02507752 ·Status: COMPLETED
-
A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis
NCT01382940 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting
NCT05487703 ·Status: COMPLETED
-
An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis
NCT01543503 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis
NCT00299130 ·Status: COMPLETED ·Phase: PHASE3
-
A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)
NCT01526057 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate
NCT00578305 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA
NCT02557295 ·Status: TERMINATED
-
Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA)
NCT02093026 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor
NCT01557348 ·Status: COMPLETED
-
A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis
NCT00299104 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate
NCT00282308 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab in Rheumatoid Arthritis Lung Disease
NCT00578565 ·Status: COMPLETED ·Phase: PHASE3
-
Stem Cell Support in Patients With Rheumatoid Arthritis
NCT00278551 ·Status: TERMINATED ·Phase: PHASE1
-
Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy
NCT01521884 ·Status: COMPLETED
-
A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis
NCT01251120 ·Status: TERMINATED ·Phase: PHASE4
-
Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis
NCT00963703 ·Status: COMPLETED ·Phase: NA
-
A Retrospective Chart Review of MabThera (Rituximab) Treatment in Rheumatoid Arthritis (RA) Participants in Australia
NCT02564770 ·Status: COMPLETED
-
Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis
NCT00425932 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Examine Efficacy and Safety of Rituximab in Participants With Rheumatoid Arthritis
NCT02699892 ·Status: COMPLETED
-
Longterm Followup of Patients With Rheumatoid Arthritis Treated With Methotrexate
NCT02641977 ·Status: COMPLETED
-
A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies
NCT02097745 ·Status: COMPLETED ·Phase: PHASE3